RxDoctor Payments DataLook up a doctor →

Tamara Doehner, MD

Hospitalist · Omaha, NENPI 1336195379

Payments from drug & device makers

$6,085,300in general payments, 2019–2025

Across 1,282 payments — averaging $4746.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$3.5M
  • Bavarian Nordic A/s$1.4M
  • Pfizer$1M
  • GSK$93K
  • Cue Health Inc.$90K
  • AstraZeneca$34K
  • plus $39K from 2 others

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Modernatx, Inc.1,061$3,461,560
Bavarian Nordic A/s116$1,363,982
Pfizer71$1,003,255
GSK26$93,173
Cue Health Inc.2$90,030
AstraZeneca2$33,900
Acadia Pharmaceuticals Inc3$33,900
Seqirus USA Inc1$5,500

How this compares

$6,085,300 in reported general payments places this provider in the 95th percentile of 124 hospitalist providers in Nebraska.

See all hospitalist providers in Nebraska

Medicare billing

Part B allowed, 2024
$45,052
Medicare patients
146
Services billed
445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hospitalist in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →